Aging-Dependent Changes in Adipose Tissue
脂肪组织的衰老依赖性变化
基本信息
- 批准号:10536237
- 负责人:
- 金额:$ 4.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-12-01 至 2026-11-30
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAblationAdipocytesAdipose tissueAdolescenceAgeAgingAreaAutomobile DrivingBindingBinding SitesBiological AssayBlood VesselsCardiovascular DiseasesCell CountCell ProliferationCell SizeCellsChIP-seqChromatinDefectDepositionDevelopmentDiseaseDisease ProgressionEquilibriumExhibitsFamilyFatty acid glycerol estersFibroblastsFutureGene ExpressionGenerationsGenetic TranscriptionGlucose tolerance testHealthHematopoieticHumanHyperphagiaHyperplasiaHypertrophyImpairmentInsulin ResistanceKnockout MiceLeadLipidsLongevityLuciferasesLymphoidMeasuresMediatingMetabolicMetabolic DiseasesMetabolismMusMyelogenousNon-Insulin-Dependent Diabetes MellitusObesityOrganPathogenesisPathologicPopulationPromoter RegionsProteinsReportingResearchRoleSiteStromal ChangeStructureT-LymphocyteTestingTherapeuticTissuesVisceraladipocyte differentiationagedcell typechromatin remodelingconditional knockoutcytokineenergy balancegranulocytein vivoin vivo evaluationinsulin tolerancelipid biosynthesismacrophagenovel therapeuticsprecursor cellprogramspromoterrecruitsingle-cell RNA sequencingstem cellssubcutaneoustranscription factortranscriptome
项目摘要
Abstract
White adipose tissue (WAT) is a metabolically active organ that is adaptive and undergoes changes throughout
the human lifespan. While adipocyte number can increase via recruitment of precursors in the stromal vascular
fraction (SVF) of WAT to differentiate into adipocytes, the total number of adipocytes in WAT is set mainly
during adolescence, and thus changes in WAT mass, adiposity, mostly reflect alterations in lipid storage. In
obesity, WAT may become severely dysfunctional and does not expand properly to store the excess energy,
resulting in ectopic fat deposition and lipotoxicity in other tissues. Unhealthy expansion of WAT by adipocyte
hypertrophy (increasing cell size) may also result in deleterious effects, such as insulin resistance and type 2
diabetes. In addition, SVF populations may drastically change and be contributing factors towards disease
progression. Hence, maintaining white adipose tissue with balance between adipocyte hypertrophy and
hyperplasia (increasing cell number) is important for whole-body metabolism and energy balance. In general,
WAT is categorized as either subcutaneous (SAT) or visceral (VAT) adipose tissue. SAT provides insulation
and cushioning and serves as a long-term energy storage depot. VAT cushions and maintains distance
between organs and is critical for lipid storage during hyperphagia. While VAT is associated with pathological
conditions, such as insulin resistance and cardiovascular disease, SAT is protective against these diseases.
During aging, VAT tends to increase while SAT decreases significantly. VAT expansion occurs as lipid storage
is shifted from SAT to VAT and visceral adipocyte hypertrophy increases. However, the explanation behind the
decrease in metabolically protective SAT mass during aging has been more elusive. Although the
developmental origin and function of VAT and SAT are known to differ, in general, the proliferation and
differentiation capacities of adipose precursor cells (APCs) in each depot are believed to drastically decline
during aging. I have recently reported that aging-dependent regulatory cells (ARCs) emerge and accumulate
as a unique subpopulation of SAT during aging. ARCs arise from APCs but exhibit impaired differentiation
capacity and express high levels of proinflammatory cytokines.
By secreting cytokines, such as Ccl6, ARCs
inhibit the proliferation and differentiation of neighboring bona fide APCs. Thus, the emergence of ARCs is
responsible for the drastic decrease in adipose precursors and defects in adipogenesis, resulting in the loss of
SAT during aging. Interestingly, the transcription factor PU.1 is the driver for the development of ARCs in SAT
during aging. Though I have shown PU.1 to be responsible for the development of ARCs, the exact
mechanism by which PU.1 alters the transcriptome of ARCs is currently unknown. Therefore, the objective of
the proposed study will be to 1) identify the mechanism by which PU.1 alters gene expression in ARCs and to
2) characterize the role of PU.1 on SAT function in vivo.
抽象的
白色脂肪组织(WAT)是一种代谢活跃的器官,具有适应性并在整个过程中经历变化
人类的寿命。虽然脂肪细胞数量可以通过基质血管中前体细胞的募集来增加
WAT分化为脂肪细胞的分数(SVF),主要设定WAT中脂肪细胞的总数
青春期期间,WAT 质量和肥胖的变化主要反映了脂质储存的变化。在
肥胖,WAT 可能会严重失调,无法正常扩张以储存多余的能量,
导致其他组织异位脂肪沉积和脂毒性。脂肪细胞 WAT 的不健康扩张
肥大(细胞大小增加)也可能导致有害影响,例如胰岛素抵抗和 2 型糖尿病
糖尿病。此外,SVF 种群可能会发生巨大变化,并成为导致疾病的因素
进展。因此,维持白色脂肪组织与脂肪细胞肥大和脂肪细胞肥大之间的平衡
增生(细胞数量增加)对于全身新陈代谢和能量平衡很重要。一般来说,
WAT 分为皮下 (SAT) 或内脏 (VAT) 脂肪组织。 SAT 提供绝缘
和缓冲,并作为长期能量储存库。增值税缓冲并保持距离
器官之间的相互作用,对于进食过多期间的脂质储存至关重要。虽然增值税与病理相关
SAT 可以预防这些疾病。
在老化过程中,VAT 趋于增加,而 SAT 则显着下降。脂质储存导致增值税扩大
从SAT转向VAT,内脏脂肪细胞肥大增加。然而,背后的解释
衰老过程中代谢保护性 SAT 质量的减少更加难以捉摸。虽然
众所周知,VAT 和 SAT 的发育起源和功能是不同的,一般而言,增殖和
人们认为每个储存库中的脂肪前体细胞(APC)的分化能力急剧下降
老化期间。我最近报道了衰老依赖性调节细胞(ARC)的出现和积累
作为衰老过程中 SAT 的一个独特亚群。 ARC 源自 APC,但表现出分化受损
能力并表达高水平的促炎细胞因子。
通过分泌细胞因子,如Ccl6、ARCs
抑制邻近真正 APC 的增殖和分化。因此,ARC的出现
导致脂肪前体急剧减少和脂肪生成缺陷,导致脂肪损失
老化期间的SAT。有趣的是,转录因子 PU.1 是 SAT 中 ARC 发展的驱动力
老化期间。虽然我已经证明 PU.1 负责 ARC 的开发,但确切的
PU.1 改变 ARC 转录组的机制目前尚不清楚。因此,目标是
拟议的研究将是 1) 确定 PU.1 改变 ARC 基因表达的机制并
2)表征PU.1对体内SAT功能的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Frances Lin其他文献
Frances Lin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
微波敏感型铁死亡纳米放大器的构建及其增敏肝癌消融-免疫联合治疗的应用与机制研究
- 批准号:82302368
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
低密度中性粒细胞促进早期乳腺癌微波消融治疗后复发转移的作用及机制研究
- 批准号:82303710
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
纳米刀消融通过METTL5介导的核糖体18S rRNA m6A修饰募集MDSC促进肝癌复发的作用及机制研究
- 批准号:82373004
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
典型草原不同退化类型雪水消融过程水分转换效率研究
- 批准号:32360295
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
基于荷顺铂温敏纳米凝胶载KU135介入栓塞联合射频消融治疗肝癌的实验研究
- 批准号:82302331
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Defining the role of Wnt11 and Wnt5a in regulating hematopoietic and skeletal stem cell self-renewal potential during homeostasis and stress
定义 Wnt11 和 Wnt5a 在稳态和应激过程中调节造血和骨骼干细胞自我更新潜力的作用
- 批准号:
10731650 - 财政年份:2023
- 资助金额:
$ 4.29万 - 项目类别:
Mechanistic Connection between Interorganellar Communication and Obesity-associated Diseases
细胞器间通讯与肥胖相关疾病之间的机制联系
- 批准号:
10634347 - 财政年份:2023
- 资助金额:
$ 4.29万 - 项目类别:
Investigating Isthmin as an adipose-to-muscle messenger that promotes muscle protein synthesis
研究 Isthmin 作为促进肌肉蛋白质合成的脂肪到肌肉信使
- 批准号:
10664500 - 财政年份:2023
- 资助金额:
$ 4.29万 - 项目类别:
Mechanisms and therapeutic potential of blocking the mitochondrial Mg2+ channel Mrs2 in obesity and NAFLD
阻断线粒体 Mg2 通道 Mrs2 在肥胖和 NAFLD 中的机制和治疗潜力
- 批准号:
10679847 - 财政年份:2023
- 资助金额:
$ 4.29万 - 项目类别: